 |
|
Professor Farber to FCC |
|
To the University Community: The theme for this year's celebration of the birth of Dr. Martin Luther King, Jr. is The Importance of King's Philosophy and Action for the 21st Century. We encourage all faculty, staff and students to participate in some of the many commemorative programs being held between January 17 and January 28. Release time has been authorized for staff to attend Martin Luther King, Jr. Day commemorative programs on January 17, and supervisors are encouraged to be flexible in granting release time and making arrangements for coverage of responsibilities. Likewise, faculty are encouraged to be flexible regarding class attendance to allow students the opportunity to participate fully in January 17 programming. --Judith Rodin, President --Robert Barchi, Provost --John Fry, Executive Vice President |
New Vice President Finance & Treasurer
Craig Carnaroli, director of the Health Care Finance Department at Merrill Lynch & Co., has been named Vice President for Finance and Treasurer at Penn by Executive Vice President John A. Fry.
As Vice President for Finance and Treasurer, Mr. Carnaroli is responsible for the University's financial planning processes and coordinates the financial activities for the University and its component parts. He is directly responsible for the offices of the Comptroller, Treasurer, Investments, Student Financial Services, Risk Management, Research Services and Acquisition Services.
"Craig is an outstanding financial executive, who has spent his entire career in public finance investment banking, working primarily with hospitals and colleges and universities," said Mr. Fry. "His expertise in these areas will enable him to lead the Division of Finance forward in a strategic and progressive manner, as well as enable him to play a key role in planning financial strategies for the University and the Health System."
Mr. Carnaroli joined Merrill Lynch in 1995, where he led a team of professionals responsible for structuring and marketing tax-exempt and taxable debt issues for non-profit education and healthcare institutions. During the course of his investment banking career, Mr. Carnaroli raised over $5 billion of capital for non-profit institutions. His accomplishments include the implementation of a debt recapitalization for an academic health system, the introduction of a new credit to the capital markets through the formation of an obligated group comprised of community-based Catholic hospitals, and development of a rating agency strategy resulting in the first "Aaa/AAA" rating for a private secondary school.For the past year, he has been advising the University and its Health System on a broad range of financial strategy, rating agency and institutional investor relations issues.
Mr. Carnaroli came to Merrill Lynch from CS First Boston, where he had served most recently as Vice President, Municipal Securities Division. While at CS First Boston, he assisted the University in the development of the Health System's borrowing structure through the development of the Master Trust Indenture. He joined CS First Boston in 1985.
He received a B.S. in Economics cum laude from the Wharton School, and an M.B.A. from the Stanford University Graduate School of Business.
Mr. Fry said Mr. Carnaroli's appointment is expected to be approved by Penn's Board of Trustees at its Stated Meeting in February.
$6.5 Million for Center of Excellence
for Autoimmune Disease
The Medical Center has received a five-year $6.5 million grant from the National Institutes of Health (NIH) to establish the new Penn Center of Excellence for Autoimmune Disease.
"Our goal for the center is to try to translate knowledge from basic science into clinical practice, focusing first on multiple sclerosis (MS) and systemic lupus erythematosus (SLE)," said Dr. Mohamad Rostami, professor of neurology and director of the new center. Dr. Rostami and the rest of the center's investigators will use animal models to learn how these diseases are produced and ultimately, how to treat them. The final step will be attempting to bridge treatment from animal to human studies.
Dr. Rostami is currently the principal investigator of a study to prevent the relapse of MS by neutralizing interleukin-12 with antibodies. According to Dr. Rostami, "we have been able to prevent relapses in the mice with EAE using antibodies interleukin-12 for the first time. Most treatments for MS are first tried out in the experimental EAE model before being tested in humans. This research, therefore, represents another possible therapy for MS patients." The study, which was originally successful with mouse models, will soon include human MS patients.
Dr. Robert A. Eisenberg, professor of medicine and neurology, is the principal investigator of the SLE study, which involves destroying pathogenic B cells. Dr. Eisenberg's general research interests are cellular, biochemical, and genetic mechanisms of systemic autoimmunity.
Other faculty members of the Center of Excellence for Autoimmune Disease include: Dr. Daniel A. Albert, associate professor of medicine; Dr. Phillip Cohen, professor of medicine; Dr. Steven L. Galetta, professor of neurology; Dr. Malek Kamoun, professor of pathology and laboratory medicine; and Dr. Burton Zweiman, emeritus professor of medicine and neurology.
Almanac, Vol. 46, No. 16, January 11, 2000
| FRONT PAGE | CONTENTS | JOB-OPS | CRIMESTATS | Appointments & Promotions | MLK Commemorative Celebration & Symposium | TALK ABOUT TEACHING ARCHIVE | BETWEEN ISSUES | JANUARY at PENN |